Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-194051
Filing Date
2026-04-30
Accepted
2026-04-30 07:40:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2026proxy_defa14a.htm DEFA14A 27586
2 GRAPHIC img53096847_0.jpg GRAPHIC 1290854
3 GRAPHIC img53096847_1.jpg GRAPHIC 297164
  Complete submission text file 0001193125-26-194051.txt   2215788
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40881 | Film No.: 26920119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)